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BACKGROUND: Obstructive sleep apnoea is the most common form of sleep-disordered breathing in 
adults and children. It is associated with many adverse health consequences. The objectives this study 
were to determine the prevalence, awareness and reporting of symptoms of obstructive sleep apnoea 
among hospitalized adult patients in Nigeria. 
METHODS: This was a multicenter cross-sectional study involving 1420 adult patients admitted to 
general medical and surgical wards of selected hospitals from March to April 2013. A questionnaire 
embedded with Berlin questionnaire, Epworth sleepiness scale and questions on level of awareness and 
reporting of symptoms of sleep apnoea was used for data collection. 
RESULTS: One-third of the patients (33.4%) reported snoring, 16.3% had excessive daytime sleepiness, 
10.0% experienced daytime fatigue, and 8.0% experienced drowsy driving. Approximately 5% reported 
witnessed apnoea and 18.0% had high risks for obstructive sleep apnoea. The frequency of high risk for 
sleep apnoea increased with age and declined after 65 years and also increased with the body mass index. 
Snoring, excessive daytime sleepiness and high risk for obstructive sleep apnoea were more common in 
patients with chronic medical conditions and who were admitted to the urban hospitals. The majority 
were not aware that snoring (77.3%) and excessive daytime sleepiness (65.8%) constitute a medical 
problem, and only 4.5% reported these symptoms to their doctors. 
CONCLUSIONS: The level of awareness and under-reporting of sleep apnoea symptoms are poor. The 
high prevalence of obstructive sleep apnoea symptoms from this study should form the basis for 
screening hospitalized patients with chronic medical condition across the country. 
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Obstructive sleep apnoea (OSA) is one of the most 
important medical conditions identified in the past 
50 years (1). Globally, it is by far the most 
common form of sleep-disordered breathing in 
adults and children and is associated with many
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other adverse health consequences, including 
increased risk of death (1-4). Untreated, sleep 
apnoea is known to cause a significant socio-
economic burden as a result of its effects on 
employment, lost income and increased healthcare 
utilization (5-6). Obstructive sleep apnoea is 
defined by the occurrence of daytime sleepiness, 
loud snoring, witnessed breathing interruptions or 
awakening due to gasping or choking in the 
presence of  five obstructive respiratory events 
(apnoeas, hypopneas and respiratory effort related 
arousal) per hours of sleep (7).   
The predisposing factors for OSA include 
obesity, male gender, ethnicity and nasal 
obstruction; large tonsils (particularly in children). 
Other risk factors include an underactive thyroid 
gland; use of alcohol, tobacco, and sedatives and 
menopause in women (1-7).  
            Berlin questionnaire is a simple screening 
tool used to identify  subjects who are at high risk   
for OSA and diagnosed by an overnight 
polysomnography (PSG) in a sleep laboratory or 
at home by a portable diagnostic monitoring and 
auto-adjusting therapeutic (1,7,8). The gold 
standard for management is continuous positive 
airway pressure (CPAP), in addition to behavioral 
therapy and physical and/or mechanical 
interventions (7).   
        OSA affects 2-4% of the middle-aged male 
population and two percent of children aged 8 to 
11 years in the USA (7-11). Adewole, et al in a 
community-based study in Abuja, Nigeria, found 
that 22% of men and 16% of women were at high 
risk for sleep apnoea and were likely to have 
obesity, sleepiness and chronic medical conditions 
(12). Other studies in southwestern Nigeria have 
also found a high prevalence of snoring and risk of 
OSA among hypertensive and heart failure 
subjects attending an outpatient clinic (13-15).  
         Acute and chronic conditions may increase 
obstructive sleep apnea manifestation (1-2). The 
hospitalization of a patient with OSA can present 
an opportunity for screening, diagnosis and 
management of the condition. The majority of the 
individuals with the condition under-report their 
symptoms and remain under diagnosed even at 
presentation in the hospital (11). There is no study, 
to our knowledge, that has evaluated the level of 
prevalence, awareness, and reporting of symptoms 
of OSA among hospitalized patients in Nigeria. 
The objectives of this study were to determine the 
prevalence, awareness and reporting of obstructive 
sleep apnoea symptoms among hospitalized adult 
patients in medical and surgical wards in Nigeria.  
 
PATIENTS AND METHODS 
 
Study Design: This was a multicenter cross-
sectional study involving adult patients admitted 
into general medical and surgical wards of six 
selected Nigerian hospitals. It was conducted from 
March 2013 to April 2013.  
 
Study setting: This study was conducted in 
Nigeria, a country located in West Africa and is 
divided into six geopolitical zones. The country 
has a population of about 145 million, with over 
250 languages and an annual growth rate of 2 %. 
The setting of this survey was six tertiary hospitals 
in Nigeria. The investigators selected four 
university teaching hospitals and two federal 
medical centres which had estimated 800-bed 
spaces in the medical and surgical wards and 
average monthly bed occupancy rate of 80%. 
These hospitals were selected for reasons of 
geographical spread and easy coordination by the 
investigators. 
Sample size and selection: The sample size was 






n = sample size, prevalence of 
snoring which is 30% from previous study (12); 
the q = (1 – p), z = standard normal deviation 
usually set at 1.96 which corresponds to the 95% 
confidence interval. d = degree of accuracy was 
set at 0.05.The calculated sample size was 338 
after adjusting for 5% non-response obtained by 
pretesting of the questionnaire. The estimated 
average patients’ turnover over a period of two 
months was 1280 and less than 10000. Cochran’s 
correction formula was used to calculate the 
minimum sample size. This calculation is as 
follows: n = 338/ (1 + 338/1280) = 258. We used a 
design effect (DEFF) of 1.0, six age strata, and the 
final sample size was approximately 1600. The 
design effect (DEFF) of 1.0 was used because age 
strata distributions across the centres did not 
significantly differ from each other despite the 
variation in the size of the centres (17). The 
estimated sample size was distributed 
proportionally based on the total number of bed 
and occupancy rate in the participating centres. 
 
Sample selection: A simple random sampling 
method was adopted because it provided less 




opportunity for errors caused due to confusion. 
We made a first sampling frame consisting of 
patients in each ward, and each patient was 
allocated number starting from 1 in ascending 
order on the first day of commencing the study. 
Subsequent patients who were admitted were also 
allocated their numbers which were quite different 
from the previous ones. All patients with allocated 
odd numbers were randomly selected until the 
sample size was attained. Eligible patients were 
approached by the resident, who provided patient 
information, consent form and verbal explanation 
of the study. The patients who provided consent 
and met the inclusion criteria were recruited as 
study participants.  
 
Inclusion and exclusion criteria: The inclusion 
criteria were patients of at least 18 years of age, 
willingness to participate, admitted into medical 
and surgical wards, conscious and 
hemodynamically stable. Patients with language 
barriers to participation were also included 
whenever translation was available by the 
interpreter. The exclusion criteria were an 
unwillingness to participate in the study and 
cognitive impairment and unconsciousness.  
Anonymity and confidentiality of the participants 
and their information were guaranteed by the 
investigators. 
 
Survey instrument: A questionnaire embedded 
with Berlin questionnaire, Epworth sleepiness 
scale and questions on patients’ level of awareness 
and reporting of symptoms of OSA was used for 
data collection. Furthermore, the survey 
instrument was also used to obtain socio-
demographic information, comorbidity and use of 
sedative and alcohol, tobacco smoking, family 
history of relatives with snoring/EDS. 
 
Data collection: The questionnaire was 
administered by residents in the department of 
internal medicine who were trained by the 
supervisor in charge of each centre. They were 
made to complete a self-interview to become 
familiar with the survey instrument and also had 
scripted practice sessions with the supervisor, and 
the likely problems were discussed. The patients 
who were unable to read English were helped with 
the questionnaire translated into the three major 
Nigerian languages. We also made an arrangement 
for the translation into Fulani language for those 
who could not communicate in English and Hausa 
in the Yola study site in the North East. 
Fortunately, all the recruited subjects were able to 
speak and comprehend English or one of the three 
major languages. To reduce recall bias, an 
additional collection of information from persons 
who shared the same bedroom and sleep on the 
same bed was made. 
Anthropometric indices in the form of 
waist/hip circumference, body weight (kg) and 
height (centimetre) were measured and body mass 
index calculated and expressed in Kg/m
2
. Obesity 
was defined as body mass index of ≥30 Kg/m
2
. 
Blood pressure was measured and hypertension 
was diagnosed by either a persistent blood 
pressure >140/90mmHg or the use of 
antihypertensive medications (18). 
 
Frequency and risk of excessive sleepiness, 
OSA symptoms: The risk of OSA and excessive 
daytime sleepiness were established by validated 
Berlin questionnaire (8) and Epworth sleepiness 
scale (18). These two questionnaires have not been 
validated in any of the Nigerian languages. The 
Berlin questionnaire and Epworth sleepiness scale 
were tested for comprehensibility and translated, 
with back translation into English in the major 
three of the 250 Nigerian languages.   In scoring 
the questions, answers were scored as a positive or 
negative response. Based on the scoring, they 
were sub-classified into three scoring categories: 
predetermination of a high risk and low risk of 
OSA using the Berlin Questionnaire was 
determined on the basis of the responses in 3 
symptom categories. In category 1, high risk was 
defined as persistent symptoms (>3 to 4 
times/week) for ≥2 questions about snoring. In 
category 2, high risk was defined as persistent (>3 
to 4 times/week) daytime tiredness or fatigue. In 
category 3, high risk was defined as a history of 
high blood pressure or a body mass index >30 
kg/m2. To be considered as a high risk for OSA, a 
patient had to qualify for ≥2 symptom categories. 
Those who reported not having persistent 
symptoms or who qualified for only one symptom 
category were placed in the lower risk group. The 
Epworth Scoring Scale (ESS) ranges from 0 to 24, 
and scores >10 were associated with excessive 
daytime sleepiness. ESS Score of 1-6 = Good, 7 - 
10 = Okay and 11 or higher = high risk for 
excessive daytime sleepiness. Where possible, the 
interviewer notified the participant about the risk 





of OSA, excessive daytime sleepiness and the 
need for further evaluation.  
 
Recognition and reporting of OSA symptoms: 
To determine the patients’ level of awareness of 
the symptoms of OSA, they were asked the 
following questions: (a) Do you consider snoring 
to be a medical problem? (b)  Do you consider 
excessive sleeping during the daytime to be a 
medical problem? (c) Have you reported or sought 
the advice of a doctor in relation to OSA 
symptoms during recent hospital visits. The 
responses to the questions were expressed as ‘yes 
/no’ or ‘don’t know’.  
 
Data analysis: The data were analyzed using 
Statistical Package for the Social Sciences (SPSS) 
software version 15 (SPSS Inc., Chicago, IL, 
USA). Descriptive statistics were used to examine 
the general characteristics of the patients. The 
demographic variables, which were normally 
distributed, were described as a mean and standard 
deviation. A comparison between groups was 
made with the Student independent  ‘t’ test and 
Mann-Whitney U. Categorical variables were 
reported as frequency distribution and compared 
using the chi-square test or Fisher’s exact test.   A 
P-value of < 0.05 was considered statistically 
significant. 
 
Ethical approval: The study was approved by the 
ethics and research committee of the respective 
study institutions.  All patients gave either verbal 




Characteristics of the patients: A total of 1591 
patients were admitted to the medical and surgical 
wards of the selected hospitals and they were 
informed about the study. Only 1420 patients met 
the inclusion criteria and were enrolled in the 
study with a completion rate of 89.3%.The median 
age of the patients was 45 years with inter-quartile 
range (IQR of 32-60 year); 747(52.6%) were 
females and 889(62.6%) had one or more co-
morbidity with 589(40.1%) having hypertension 
which was the commonest comorbidity.  Five 
hundred and thirty-seven (37.8%) had a first-
degree relative with snoring or excessive 
sleepiness (Table 1). 
 






Prevalence and Risk of OSA symptoms: A total 
474(33.4%) patients reported snoring, 144(26.4) 
had loud snoring, 70(4.9%) reported witnessed 
apnoea, 142(10.0%) had daytime fatigue and 
114(8.0%) reported drowsy driving. Two hundred 
and thirty-one patients (16.3%) had excessive 
daytime sleepiness (EDS), i.e. the Epworth 
Sleepiness Scale >10 and 256(18.0%) had a high 
Characteristics  N (%)  
Median age (Q1-Q4) in years 












None /primary  
Secondary   
Tertiary  









Presence of Chronic medical 
condition  
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Use of sedatives  156(11.0) 
Tobacco smoking 164(11.5) 
Alcohol consumption 342(24.1) 
First-degree relative snoring or 
excessive sleepiness 
537(37.8) 




risk for OSA. Men had a significantly higher 
frequency of persistent snoring, daytime fatigue 
and drowsy driving than women. The Berlin 
scores and Epworth scores for the risk of OSA and 
excessive daytime sleepiness respectively were 
also higher among men than among women (Table 
2).  
Patients with chronic medical diseases 
(CMD) significantly had higher frequency of 
snoring (43.6% vs.16.2%), high risk for OSA 
(27.9% vs.1.5%) and EDS (18.3% vs.5.8 %) than 
those without CMD (Table 3). 
 
Table 2: Symptoms and risk of obstructive sleep apnoea (OSA) by Gender. 
 
 
Symptoms   Male  





Snoring  248(36.8) 226(30.3) 474(33.4)* 
Loud snoring 78(27.9) 66(24.8) 144(26.4) 
Persistent  snoring 134(19.9) 116(15.5) 250(17.6)* 
Snoring bothering others 140(20.8) 122(16.3) 262(18.5)* 
Witnessed apnoea   38(5.6) 32(4.3) 70(4.9) 
Daytime Fatigue  78(11.6) 64(8.6) 142(10.0) 
Unrefreshing  sleep 80(11.9) 58(7.8) 138(9.7)* 
Drowsiness  on steering 80(11.9) 34(4.6) 114(8.0)* 
Risk for sleep apnoea     
Low risk 547(81.3) 617(82.6) 1164(82.0) 
High risk 126(18.7) 130(17.4) 256(18.0) 
Excessive daytime sleepiness(ESS>10) 113(16.8) 118(15.8) 231(16.3) 
Data are presented as n (%), ESS-Epworth Sleepiness Scale, *p values<0.05 
 
Table 3: Symptoms and risk of obstructive sleep apnoea (OSA) by CMD 
 
Symptoms   CMD  





Snoring  388(43.6) 86(16.2) 474(33.4)* 
Loud snoring 112(12.6) 32(6.0) 144(26.4) 
Persistent  snoring 222(25.0) 28(5.3) 250(17.6)* 
Snoring bothering others 230(25.9) 32(6.0) 262(18.5)* 
Witnessed apnoea   58(6.5) 12(2.3) 70(4.9)* 
Daytime Fatigue  114(12.8) 28(5.3) 142(10.0)* 
Unrefreshing  sleep 118(13.3) 20(3.8) 138(9.7)* 
Drowsiness  on steering 84(9.4) 30(5.6) 114(8.0)* 
Risk for sleep apnoea     
Low risk 641(72.1) 523(98.5) 1164(82.0) 
High risk 248(27.9) 9(1.5) 256(18.0)* 
Excessive daytime sleepiness(ESS>10) 132(18.3) 72(5.8) 231(16.3)* 
Data are presented as n (%), ESS-Epworth Sleepiness Scale, *p values <0.05 
 
The frequency of high risk for OSA increased 
from the age of 18 years and peaked within the 
age range of 40-64 years, then declined after 65 
years (Figure 1). Similarly, high risk for sleep 
apnoea also increased with the body mass index. 
The frequency of high risk for OSA was 66.7% in 
patients with morbid obesity and 4.3% in those 
who were underweight (Figure 2). 
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Figure 2: High Risk for OSA by Body mass index 
 
By hospital location, out of the 766 subjects 
recruited in the urban hospitals, 280(36.6%) had 
snoring, 126(16.5%) had excessive daytime 
sleepiness and 150(19.6%) had a high risk for 
OSA. Out of 654 subjects in the semi-urban and 
rural hospitals, 194(29.7%) had snoring, 
104(16.0%) had excessive daytime sleepiness and 








Table 4: Symptoms and risk of OSA by Hospital location. 
 
 
Symptoms   Urban  














High risk for sleep apnoea  150(19.6) 10616.2) 256(18.0)* 
Data are presented as n (%), ESS-Epworth Sleepiness Scale *p values<0.05  
 
Awareness and Reporting of OSA symptoms 
 
The majority of the patients were not aware that 
snoring (77.3%) and excessive daytime sleepiness 
(65.8%) constitute a medical problem. Only 4.5% 
of them sought their doctor’s advice during 
hospital visits for sleep apnoea symptom. The 
patients at high risk for OSA were more likely to 
be aware of the medical importance of the 
condition and report their sleep apnoea symptoms 
to their doctors than the low-risk patients (Table 
5).  
 
Table 5: Awareness and reporting symptoms of OSA. 
  
 
 Awareness statement  Low risk  High risk Total  P value  















Excessive sleeping during the daytime is   a medical 

































The findings of this study revealed that one-third 
of the patients reported snoring, 16.3% had 
excessive daytime sleepiness, 10.0% experienced 
daytime fatigue, and 8.0% experienced drowsy 
driving. Approximately 5 % reported witnessed 
apnoea and 18.0% had high risks for obstructive 
sleep apnoea. Sixteen percent had excessive 
daytime sleepiness (EDS) and 18% had a high risk 
for OSA. Persistent snoring, daytime fatigue, 
drowsiness on the steering wheel, excessive 
daytime sleepiness and high risk for OSA were 
frequently higher in men than in women in this 
study. Patients with chronic medical conditions 
(CMD) had significantly higher frequency of OSA 
symptoms, high risk of OSA and excessive 
daytime sleepiness than those without chronic 
medical condition. The majority of the patients 
and especially the females and low-risk patients 
were not aware or fail to recognize that snoring 
and EDS are medical problems. Only 4.5% had 
reported their sleep apnoea symptoms to their 
doctors.  
The prevalence of snoring obtained in this 
study is comparable to 36% from primary care 
facilities in the USA but lower than 40-52% 
reported in studies conducted in Saudi Arabia (21-
23). In addition, it is higher than 22% in Turkey, 
24.9% in Pakistan, 26% in Europe and 28.7% in 
Jordan (21, 24-26).  
  Our study revealed that 16% had EDS, 10% 
experienced daytime fatigue and 8% reported 
drowsiness while driving. This observation is 
similar to 10% drowsy driving reported from a 
study in Pakistan (25), while it is lower than 12-
23% in the USA and 4-14% in Europe (21).  
Drowsiness while driving   is a major public 
health hazard and is associated with increased risk 
of motor vehicle accident and poor occupational 





performance. Therefore, early diagnosis and 
treatment programs are needed for people who are 
at risk. The variations in results of symptoms in 
the different studies might be due to the diagnostic 
criteria and methodologies adopted in conducting 
these studies, variation in age of study population, 
cephalometric variations influenced by genetic 
factors  and burdens of chronic medical 
conditions.  
    We also observed the predominance of these 
symptoms in male patients than in female patients. 
Our finding is in agreement with other studies (21-
26), whereas studies from Saudi Arabia reported a 
higher frequency of witnessed apnea among 
female patients (23-24).  
        Prevalence of high risk for OSA using Berlin 
questionnaire was 18%, and is higher than 10% 
reported from Pakistan, but it is comparable to 
17.4% found in  Southwestern Nigeria, 16.8% in 
Jordan and 20.9% in the United Arab Emirates 
(13,26,27). The prevalence of high risk for OSA is 
higher in the western world, as 26-36% was 
observed in the USA and Europe and 33-39% in 
Saudi Arabia (21, 23-24).  
Furthermore, male patients had a higher risk 
of sleep apnoea than female patients. This result is 
in agreement with other studies (13, 21, 26). This 
male predominance can be due to gender 
differences in the tobacco smoking, alcohol use, 
adipose tissue distribution, upper airway anatomy 
and muscle function, control of ventilation, and 
the effects of sex hormones and leptin (10). In 
contrast to our study, three studies in conducted in 
the Middle East reported that female patients were 
more prone to sleep apnea (23-24, 27). These 
findings can be explained by the high prevalence 
of female obesity in that population (1, 2). The 
female populations in the Middle East are mostly 
in purdah because of their religious beliefs. This 
often leads to limited outdoor activities, inactivity 
and excessive calorie retention resulting in weight 
gain. 
Findings from this study also showed that 
chronic medical conditions were associated with 
high of risk sleep apnea. This finding is in 
concordance with other studies (12-14, 28, 29).  
  The result of this study also revealed that 
frequency of snoring and high risk for OSA were 
significantly higher in subjects who attended 
urban hospitals than the ones in semi-urban and 
rural hospitals.  This result is similar to studies in 
China and built up areas in the United Kingdom 
(30-31). Health care utilization of facilities are a 
direct representation of  the local population and 
therefore it can be concluded that snoring , EDS  
and the risk of sleep apnea were more prevalent 
among urban than rural residents.  This result 
suggests that risk factors for sleep apnoea and 
lifestyle are different across urban and semi-
urban/rural areas. Sedentary lifestyle and lack of 
exercise which are common in urban dwelling 
could lead to obesity and elevated body mass 
index and hypertension which are risk factors for 
sleep apnoea. In the rural areas, there is a lack of 
transport and most rural dwellers have to walk 
long distance daily to get water and carry out other 
daily chores.  This daily activity prevents them 
from becoming obese and developing high blood 
pressure. In Africa, diabetes which is risk factors 
for OSA is more common among the wealthy 
ones, hence its designation as the “disease of 
opulence,” and remains more pronounced in urban 
areas where people tend to be less physically 
active, eating diets rich in saturated fats and 
refined sugars (32). Hypertension, Obesity and 
Diabetic Mellitus are found to be more common in 
urban than in the rural areas (33). 
        The majority of the patients were not aware 
that snoring and daytime sleepiness constitute 
medical problems. The awareness of snoring and 
excessive daytime sleepiness as medical problems, 
reporting to their doctors during hospital visits 
was higher among male patients and those at high 
risk for sleep apnoea.  
Interestingly, our study also showed that 
reporting of symptoms was very low. Under-
reporting and under-recognition were reported in 
other studies (34-35). The under- reporting of 
OSA symptoms may be attributed to poor 
awareness of the condition and poor patients’ 
recall.  It may also be due to poor knowledge and 
awareness on the part of the patients regarding the 
risks and consequences of sleep apnoea. These 
results may suggest the need for a future study on 
knowledge and awareness of the physicians and 
the patients regarding the risks, consequences and 
health economics of sleep. 
The strength of our study that it is based on 
appreciable sample size of the respondents, 
widespread recruitment of patients from the urban, 
semi-urban and rural areas with varying socio-
demographic profiles and lifestyles. Despite the 




aforementioned strengths, the study has some 
potential limitations which include the possible 
recall bias on the part of the patients and their 
relatives which affect their level of reporting of 
symptoms and actual prevalence. This problem 
was addressed with an additional collection of 
information from persons who shared the same 
bedroom and sleep on the same bed.  This study 
did not capture all the seasons of the year; 
consequently, some seasonal conditions may have 
been underrepresented and others overrepresented.  
The adoption of hospital setting may have created 
some selection bias. However, this sampling 
technique provided less opportunity for errors due 
to confusion. This sampling technique also allows 
for studying patients available, giving a good 
representation of the overall patient population 
within in a reasonable period of time.   
          The prevalence of symptoms of OSA is high 
among hospitalized patients with CMD. The level 
of awareness and under-reporting of sleep apnoea 
symptoms are poor. Also, the high prevalence of 
OSA symptoms from this study should form the 
basis for screening hospitalized patients with 
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